Theravance Biopharma (NASDAQ:TBPH) Shares Gap Down to $24.67

Share on StockTwits

Theravance Biopharma Inc (NASDAQ:TBPH) shares gapped down prior to trading on Thursday . The stock had previously closed at $23.22, but opened at $24.67. Theravance Biopharma shares last traded at $25.25, with a volume of 11,718 shares trading hands.

TBPH has been the topic of several research reports. HC Wainwright boosted their price objective on shares of Theravance Biopharma from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, January 8th. ValuEngine cut shares of Theravance Biopharma from a “buy” rating to a “hold” rating in a research report on Wednesday, January 29th. Piper Jaffray Companies cut their price objective on shares of Theravance Biopharma from $55.00 to $40.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 6th. Robert W. Baird raised shares of Theravance Biopharma from an “underperform” rating to a “neutral” rating and cut their price objective for the company from $22.00 to $18.00 in a research report on Wednesday, November 6th. Finally, BidaskClub cut shares of Theravance Biopharma from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Theravance Biopharma currently has a consensus rating of “Buy” and a consensus price target of $35.75.

The firm has a market capitalization of $1.42 billion, a P/E ratio of -6.25 and a beta of 1.92. The firm’s 50-day moving average is $26.35 and its 200 day moving average is $21.67.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Tower Research Capital LLC TRC lifted its position in Theravance Biopharma by 68.7% in the 3rd quarter. Tower Research Capital LLC TRC now owns 1,798 shares of the biopharmaceutical company’s stock valued at $35,000 after acquiring an additional 732 shares in the last quarter. California State Teachers Retirement System lifted its position in Theravance Biopharma by 1.2% during the 3rd quarter. California State Teachers Retirement System now owns 68,906 shares of the biopharmaceutical company’s stock worth $1,342,000 after buying an additional 823 shares in the last quarter. Rhumbline Advisers lifted its position in Theravance Biopharma by 2.0% during the 4th quarter. Rhumbline Advisers now owns 57,916 shares of the biopharmaceutical company’s stock worth $1,499,000 after buying an additional 1,141 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in Theravance Biopharma by 72.1% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,094 shares of the biopharmaceutical company’s stock worth $80,000 after buying an additional 1,296 shares in the last quarter. Finally, Bank of Montreal Can lifted its position in Theravance Biopharma by 30.7% during the 4th quarter. Bank of Montreal Can now owns 6,496 shares of the biopharmaceutical company’s stock worth $168,000 after buying an additional 1,527 shares in the last quarter. 68.92% of the stock is currently owned by institutional investors and hedge funds.

Theravance Biopharma Company Profile (NASDAQ:TBPH)

Theravance Biopharma, Inc, a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines. The company offers VIBATIV, a bactericidal, once-daily injectable antibiotic to treat patients with serious, life-threatening infections due to staphylococcus aureus and other gram-positive bacteria, including methicillin-resistant.

See Also: How Do I Invest in Dividend Stocks

Receive News & Ratings for Theravance Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theravance Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Healthcare Services Group, Inc.  Shares Acquired by Eagle Asset Management Inc.
Healthcare Services Group, Inc. Shares Acquired by Eagle Asset Management Inc.
Sherwin-Williams Co  Position Trimmed by Coastal Investment Advisors Inc.
Sherwin-Williams Co Position Trimmed by Coastal Investment Advisors Inc.
Eagle Asset Management Inc. Purchases 1,992 Shares of UMB Financial Corp
Eagle Asset Management Inc. Purchases 1,992 Shares of UMB Financial Corp
Eagle Asset Management Inc. Sells 3,193 Shares of AeroVironment, Inc.
Eagle Asset Management Inc. Sells 3,193 Shares of AeroVironment, Inc.
Coastal Investment Advisors Inc. Sells 1,728 Shares of Weyerhaeuser Co
Coastal Investment Advisors Inc. Sells 1,728 Shares of Weyerhaeuser Co
Eagle Asset Management Inc. Sells 3,592 Shares of Kornit Digital Ltd
Eagle Asset Management Inc. Sells 3,592 Shares of Kornit Digital Ltd


© 2006-2020 Ticker Report